Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hypoglycemia and Glucagon

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Glucose Homeostasis: Regulation of Blood Glucose

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...

Hormones Regulating Blood Glucose

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...

Oral Hypoglycemic Agents: Biguanides and Glitazones

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...

Glucagon-like Receptor Agonists

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The 2026 global roadmap for textile-integrated wearable technologies in health.

Physiological measurement·2026

Same author

Safety and Glycemic Outcomes Among Youth With New-Onset Type 1 Diabetes Using a Tubeless Automated Insulin Delivery System.

Journal of diabetes research·2026

Same author

Editorial Comment.

The Journal of urology·2026

Same author

Deep Learning-Enabled Diabetic Retinopathy Screening: A Techno-Clinical Revolution or Just More Artificial Intelligence Hype?

Diabetes care·2026

Same author

Robust Prediction of Cardiorespiratory Signals from a Multimodal Physiological System on the Upper Arm.

Biosensors·2025

Same author

ROCKET T1D Remote Patient Monitoring Program: Launching Diabetes Management Habits in New-Onset Diabetes.

Clinical diabetes : a publication of the American Diabetes Association·2025

Same journal

Digital Twin Applications in Diabetes Management: Scoping Review.

JMIR diabetes·2026

Same journal

Training Community Health Workers for Diabetes Management in Low- and Middle-Income Countries: Systematic Review.

JMIR diabetes·2026

Same journal

Personalized Type 1 Diabetes Management: Reinforcement Learning-Based Insulin Dosing and Glucose Forecasting.

JMIR diabetes·2026

Same journal

Social Determinants of Health Among Chinese Americans at Risk for Diabetes in a Mobile Diabetes Prevention Trial: Cross-Sectional Baseline Analysis.

JMIR diabetes·2026

Same journal

Personalized Digital Health Solutions to Increasing Diabetes-Related Knowledge and Behavioral Outcomes: Results From a Randomized Controlled Trial.

JMIR diabetes·2026

Same journal

Quality and Guideline Adherence of Mobile Nutrition Management Apps for Diabetes: Evaluation Study.

JMIR diabetes·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Nov 7, 2025

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Improved Low-Glucose Predictive Alerts Based on Sustained Hypoglycemia: Model Development and Validation Study.

Darpit Dave¹, Madhav Erraguntla¹, Mark Lawley¹

¹Department of Industrial and Systems Engineering, Texas A&M University, College Station, TX, United States.

|April 29, 2021

Summary

This summary is machine-generated.

Predicting sustained hypoglycemic events in type 1 diabetes improves alert accuracy. Focusing on prolonged low glucose levels enhances prediction models, reducing false alarms and improving patient safety.

Keywords:

continuous glucose monitoring diabetes false alert rate glucose monitoring hypoglycemia machine learning model generalizability quantile regression forests sustained hypoglycemia

More Related Videos

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

Published on: August 12, 2016

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

Related Experiment Videos

Last Updated: Nov 7, 2025

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

Published on: August 12, 2016

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

Area of Science:

Endocrinology
Biomedical Engineering
Data Science

Background:

Hypoglycemia poses significant risks for individuals with type 1 diabetes.
Predictive alerts are crucial for timely intervention and prevention of severe hypoglycemic events.
Current prediction models require refinement for improved accuracy and generalizability.

Purpose of the Study:

To develop a robust prediction model for hypoglycemic events in type 1 diabetes.
To minimize false alert rates while maximizing sensitivity and specificity.
To ensure the model's generalizability across different patients and time periods.

Main Methods:

Explored prediction of sustained hypoglycemic events (glucose < 70 mg/dL for ≥ 15 minutes).
Compared classification-based and regression-based modeling approaches.
Employed patient-based and time-based validation to assess model robustness.

Main Results:

Utilized 1.6 million continuous glucose monitoring values from 110 patients.
Achieved >97% sensitivity and specificity for 30- and 60-minute prediction horizons.
Maintained a false alert rate below 25% with consistent validation results.

Conclusions:

Alerts focused on sustained hypoglycemic events reduce false alarms.
This approach enhances model sensitivity, specificity, and generalizability.
The developed model offers improved predictive capabilities for type 1 diabetes management.